Stockreport

FibroBiologics Announces Pricing of $3 Million Public Offering [TheStreet.com]

FibroBiologics, Inc.  (FBLG) 
PDF HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ pa [Read more]